Close

Statements and Testimony

Statement for the Record “Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs”

Immediate action is needed to transform the nation’s drug pricing system in ways that will lower prices, strengthen Medicare, and promote the well-being of those who rely on its coverage. H.R. 3 would significantly advance these goals, in part by authorizing Medicare to negotiate prices for certain drugs; imposing inflationary rebates; and restructuring Part D to cap beneficiary out-of-pocket costs at $2,000 per year, reduce the federal government’s liability, and better align pricing incentives.

Read More

Joint Principles from the Center for Medicare Advocacy and the Medicare Rights Center: Medicare Expansion of Telehealth Helps Beneficiaries Access Care During the Pandemic–But Caution is Needed Before Making These Changes Permanent

As policymakers consider the post-pandemic Medicare telehealth landscape, the Medicare Rights Center and the Center for Medicare Advocacy offer our shared perspective on next steps. In these joint principles, we urge a cautious, thoughtful, and evidence-based approach that centers the unique and evolving needs of people with Medicare.

Read More

Statement for the Record: “Open Executive Session to Consider an Original Bill Entitled the Prescription Drug Pricing Reduction Act of 2019”

Chairman Grassley, Ranking Member Wyden, and distinguished Members of the Senate Committee on Finance, on behalf of the Medicare Rights Center (Medicare Rights), thank you for your bipartisan efforts to address the problem of high and rising prescription drug prices, and for the opportunity to share our perspective on this […]

Read More

Statement for the Record Senate Health, Education and Labor Committee Full Committee Hearing Lower Health Care Costs Act

The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]

Read More

Statement for the Record Energy & Commerce Health Subcommittee Hearing “No More Surprises: Protecting Patients from Surprise Medical Bills”

The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]

Read More

Statement for the Record House Ways and Means Health Subcommittee Hearing “Protecting Patients from Surprise Medical Bills”

The undersigned organizations of the Observation Stays Coalition have come together to address a surprise medical billing issue that affects Medicare patients in hospitals who are called observation status patients or outpatients, although the medically necessary care they need and receive is no different from the medically necessary care provided […]

Read More

Part B Drug Payment Model Testimony

Medicare Rights Center President Joe Baker testimony in support of the Centers for Medicare & Medicaid Services (CMS) proposal to test new ways to pay for prescription drugs covered under Medicare Part B, at a hearing held by the Subcommittee on Health of the U.S. House Committee on Energy and […]

Read More